Allen et al v. Takeda Pharmaceutical Company Limited et al
| Terrence Allen and Susan Allen |
| Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals North America, Inc., Takeda Pharmaceuticals LLC, Takeda Pharmaceuticals International Inc., Takeda Global Research & Development Center Inc. and Takeda San Diego Inc. |
| 1:2011cv00643 |
| July 29, 2011 |
| US District Court for the Western District of New York |
| Buffalo Office |
| Wyoming |
| Richard J Arcara |
| Jeremiah J McCarthy |
| Tort Product Liability |
| 28 U.S.C. § 1332 Diversity-Product Liability |
| Defendant |
Docket Report
RSS Track this Docket
This docket was last retrieved on January 6, 2012. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 22 CERTIFIED MULTIDISTRICT LITIGATION TRANSFER ORDER transferring case to the Western District of Louisiana. Signed by John G. Heyburn II, Chairman. (DR) |
| Case transferred to MDL Western District of Louisiana. (DR) |
| Filing 21 TEXT ORDER : A telephonic conference concerning plaintiff's January 4, 2012 letter to the court is set for January 6, 2012 at 2:00 p.m. The parties shall provide chambers with a telephone number where they can be contacted. The court will initiate the call. SO ORDERED. Issued by Hon. Jeremiah J. McCarthy on 1/5/12. (DAZ) |
| Filing 20 RESPONSE in Support re #11 MOTION to Amend/Correct Answer . TAKEDAS REPLY IN SUPPORT OF ITS MOTION FOR LEAVE TO AMEND ITS ANSWER TO PLAINTIFFS COMPLAINT filed by Takeda Global Research & Development Center Inc., Takeda Pharmaceuticals International Inc., Takeda Pharmaceuticals LLC, Takeda Pharmaceuticals North America, Inc., Takeda San Diego Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B)(Garry, Colin) |
| Filing 19 TEXT ORDER: At the parties' request, the January 4, 2012 preliminary pretrial conference is adjourned to February 9, 2012 at 10:00 a.m. The parties may participate via telephone upon advance notice to chambers. SO ORDERED. Issued by Hon. Jeremiah J. McCarthy on 12/30/11. (DAZ) |
| Filing 18 MEMORANDUM in Opposition re #11 MOTION to Amend/Correct Answer filed by Susan Allen, Terrence Allen. (Pennock, Paul) |
| Filing 17 CONTINUATION OF EXHIBITS by Susan Allen, Terrence Allen. to #16 Continuation of Exhibits, #15 Affidavit in Opposition to Motion Exhibit "F" filed by Susan Allen, Terrence Allen. (Attachments: #1 Exhibit Exhibit "G")(Pennock, Paul) |
| Filing 16 CONTINUATION OF EXHIBITS by Susan Allen, Terrence Allen. to #15 Affidavit in Opposition to Motion Exhibit "C" filed by Susan Allen, Terrence Allen. (Attachments: #1 Exhibit Exhibit "D", #2 Exhibit Exhibit "E")(Pennock, Paul) |
| Filing 15 AFFIDAVIT Certification of Paul J. Pennock in Opposition re #11 MOTION to Amend/Correct Answer filed by Susan Allen, Terrence Allen. (Attachments: #1 Exhibit Exhibit "A")(Pennock, Paul) |
| Filing 14 TEXT ORDER : Plaintiff's response to defendants' motion to amend #11 shall be served and filed by December 27, 2011; defendants' reply, if any, shall be served and filed by January 3, 2012, after which time the motion #11 will be taken under advisement without oral argument unless requested by one of the parties or deemed necessary by the court. SO ORDERED. Issued by Hon. Jeremiah J. McCarthy on 12/14/11. (DAZ) |
| Filing 13 MEMORANDUM in Support re #11 MOTION to Amend/Correct Answer filed by Takeda Global Research & Development Center Inc., Takeda Pharmaceuticals International Inc., Takeda Pharmaceuticals LLC, Takeda Pharmaceuticals North America, Inc.. (Garry, Colin) |
| Filing 12 DECLARATION signed by Colin J. Garry re #11 MOTION to Amend/Correct Answer filed by Takeda Pharmaceuticals International Inc., Takeda Global Research & Development Center Inc., Takeda Pharmaceuticals North America, Inc., Takeda Pharmaceuticals LLC With Exhibit 'A' Attached filed by Takeda Pharmaceuticals International Inc., Takeda Global Research & Development Center Inc., Takeda Pharmaceuticals North America, Inc., Takeda Pharmaceuticals LLC. (Garry, Colin) |
| Filing 11 MOTION to Amend/Correct Answer by Takeda Global Research & Development Center Inc., Takeda Pharmaceuticals International Inc., Takeda Pharmaceuticals LLC, Takeda Pharmaceuticals North America, Inc..(Garry, Colin) |
Filing 10
ORDER OF PRELIMINARY PRETRIAL CONFERENCE set for 1/4/2012 at 10:30 AM before Hon. Jeremiah J. McCarthy. Signed by Hon. Jeremiah J. McCarthy on 11/29/11. (DAZ)
|
| Filing 9 TEXT ORDER REFERRING CASE to Magistrate Judge Hon. Jeremiah J. McCarthy The Magistrate Judge is hereby designated to act in this case as follows: Pursuant to 28 U.S.C. Section 636(b)(1)(A) and (B), all pre-trial matters in this case are referred to the above-named United States Magistrate Judge, including but not limited to: (1) conduct of a scheduling conference and entry of a scheduling order pursuant to Fed. R. Civ. P. 16, (2) hearing and disposition of all non-dispositive motions or applications, (3) supervision of discovery, and (4) supervision of all procedural matters involving the aforementioned or involving the preparation of the case or any matter therein for consideration by the District Judge. The Magistrate Judge shall also hear and report upon dispositive motions for the consideration of the District Judge pursuant to 28 U.S.C. Section 636(b)(1)(B) and (C). All motions or applications shall be filed with the Clerk and made returnable before the Magistrate Judge. The parties are encouraged to consider the provisions of 28 U.S.C. Section 636(c) governing consent to either partial or complete disposition of the case, including trial if necessary, by the Magistrate Judge. Consent forms are available from the office of the Magistrate Judge or the office of the Clerk of Court. IT IS SO ORDERED.. Signed by Hon. Richard J. Arcara on 11/28/2011. (JMB) |
| Filing 8 AMENDED ANSWER to by Takeda Global Research & Development Center Inc., Takeda Pharmaceuticals International Inc., Takeda Pharmaceuticals LLC, Takeda Pharmaceuticals North America, Inc.. (Garry, Colin) |
| Filing 7 ANSWER to #1 Complaint by Takeda Global Research & Development Center Inc., Takeda Pharmaceuticals International Inc., Takeda Pharmaceuticals LLC, Takeda Pharmaceuticals North America, Inc.. (Attachments: #1 Certificate of Service)(Garry, Colin) |
| Filing 6 Corporate Disclosure Statement by Takeda Global Research & Development Center Inc., Takeda Pharmaceuticals International Inc., Takeda Pharmaceuticals LLC, Takeda Pharmaceuticals North America, Inc.. (Attachments: #1 Certificate of Service)(Garry, Colin) |
| Filing 5 *** Please disregard-replaced with document #6 *** Corporate Disclosure Statement by Takeda Global Research & Development Center Inc., Takeda Pharmaceuticals International Inc., Takeda Pharmaceuticals LLC, Takeda Pharmaceuticals North America, Inc., Takeda San Diego Inc.. (Attachments: #1 Certificate of Service)(Garry, Colin) Modified on 9/20/2011 (DR). |
| Filing 4 AUTOMATIC REFERRAL to Mediation (ADR Plan attached to this entry)(JMM) |
| Filing 3 NOTICE of right to consent to proceed before a magistrate judge (Consent forms attached to this entry) (JMM) |
| Filing 2 Summons Issued as to All Defendants (Issued summons attached to this event) (JMM) (Main Document 2 replaced on 12/29/2020) (JD). |
| Filing 1 COMPLAINT Terrence Allen and Susan Allen against All Defendants ( Filing fee $ 350 receipt number 0209-1424502.), filed by Susan Allen, Terrence Allen. (Attachments: #1 Civil Cover Sheet, #2 Summons)(Pennock, Paul) |
| Case assigned to Hon. Richard J. Arcara. (JMM) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New York Western District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
